Review: taking Victoza and Glucophage together


Summary

Drug interactions are reported among people who take Victoza and Glucophage together. This review analyzes the effectiveness and drug interactions between Victoza and Glucophage. It is created by eHealthMe based on reports of 3,210 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Victoza and Glucophage >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 14,879 users)

Glucophage

Glucophage has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Glucophage 42,832 users)

On Aug, 22, 2016

3,210 people who take Victoza, Glucophage are studied.


Number of reports submitted per year:

Victoza and Glucophage drug interactions.

Drug effectiveness over time:

Victoza:
  • < 1 month: 83.0% - (5 of 6 people)
  • 1 - 6 months: 59.0% - (16 of 27 people)
  • 6 - 12 months: 56.0% - (13 of 23 people)
  • 1 - 2 years: 52.0% - (9 of 17 people)
  • 2 - 5 years: 21.0% - (3 of 14 people)
  • 5 - 10 years: 16.0% - (1 of 6 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (1 of 1 people)
Glucophage:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 17.0% - (3 of 17 people)
  • 2 - 5 years: 26.0% - (7 of 26 people)
  • 5 - 10 years: 22.0% - (6 of 27 people)
  • 10+ years: 18.0% - (2 of 11 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Victoza:
  • female: 58.0% - (29 of 50 people)
  • male: 43.0% - (19 of 44 people)
Glucophage:
  • female: 30.0% - (16 of 53 people)
  • male: 17.0% - (8 of 45 people)

Drug effectiveness by age:

Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 85.0% - (6 of 7 people)
  • 40-49: 43.0% - (10 of 23 people)
  • 50-59: 58.0% - (24 of 41 people)
  • 60+: 34.0% - (8 of 23 people)
Glucophage:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 28.0% - (2 of 7 people)
  • 40-49: 29.0% - (7 of 24 people)
  • 50-59: 27.0% - (12 of 43 people)
  • 60+: 13.0% - (3 of 23 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • vomiting
  • pancreatitis acute
  • diarrhoea
  • abdominal pain
  • renal failure acute
  • pancreatitis
  • dehydration
  • weight decreased
  • blood glucose increased
1 - 6 months:
  • pancreatitis
  • pancreatitis acute
  • nausea
  • abdominal pain
  • weight decreased
  • vomiting
  • diarrhoea
  • lipase increased
  • renal failure
  • renal failure acute
6 - 12 months:
  • pancreatitis
  • pancreatitis acute
  • renal failure acute
  • nausea
  • weight decreased
  • pancreatic carcinoma
  • abdominal pain
  • alanine aminotransferase increased
  • blood calcitonin increased
  • cholelithiasis
1 - 2 years:
  • pancreatitis
  • pancreatic carcinoma
  • pancreatitis acute
  • fatigue
  • nausea
  • weight decreased
  • cardiac failure
  • glycosylated haemoglobin increased
  • abdominal pain
  • metastases to liver
2 - 5 years:
  • nausea
  • loss of smell
  • dyspnoea
  • tension headache
  • pancreatitis acute
  • pancreatic carcinoma
  • pancreatitis
  • aortic aneurysm
  • cardiac failure
  • pancreatic pseudocyst
5 - 10 years:
  • loss of smell
  • hypertension
  • renal failure acute
  • type 2 diabetes
  • abortion spontaneous
  • depression
  • frequent or urgent urination
  • hyperlipidemia
  • insomnia
  • milk allergy
10+ years:
  • burping
  • chills
  • dementia
  • diarrhea
  • gastric ulcer
  • nausea
  • vomiting
  • cough
  • elevated liver enzymes
  • fall
not specified:
  • nausea
  • blood glucose increased
  • diarrhoea
  • weight decreased
  • vomiting
  • pancreatitis
  • decreased appetite
  • pancreatitis acute
  • blood glucose decreased
  • headache

Most common drug interactions by gender *:

female:
  • nausea
  • vomiting
  • blood glucose increased
  • diarrhoea
  • weight decreased
  • decreased appetite
  • pancreatitis acute
  • pancreatitis
  • abdominal pain
  • headache
male:
  • nausea
  • blood glucose increased
  • pancreatitis
  • diarrhoea
  • weight decreased
  • pancreatitis acute
  • vomiting
  • abdominal pain
  • decreased appetite
  • fatigue

Most common drug interactions by age *:

0-1:
  • congenital central nervous system anomaly
  • foetal malformation
10-19:
  • nausea
  • myalgia
  • pain
  • acute generalised exanthematous pustulosis
  • diarrhoea
  • headache
  • pancreatitis acute
20-29:
  • foetal death
  • maternal exposure during pregnancy
  • hypoglycaemia
  • weight decreased
  • abortion spontaneous
  • blood glucose abnormal
  • drug exposure during pregnancy
  • nausea
  • pancreatitis
  • vomiting
30-39:
  • nausea
  • vomiting
  • diarrhoea
  • malaise
  • blood glucose increased
  • dizziness
  • pancreatitis
  • erythema
  • abdominal discomfort
  • fatigue
40-49:
  • nausea
  • pancreatitis acute
  • diarrhoea
  • pancreatitis
  • vomiting
  • weight decreased
  • blood glucose increased
  • abdominal pain
  • flatulence
  • abdominal discomfort
50-59:
  • nausea
  • pancreatitis
  • pancreatitis acute
  • diarrhoea
  • vomiting
  • blood glucose increased
  • weight decreased
  • abdominal pain upper
  • headache
  • abdominal pain
60+:
  • nausea
  • blood glucose increased
  • vomiting
  • diarrhoea
  • weight decreased
  • decreased appetite
  • pancreatitis acute
  • pancreatitis
  • dehydration
  • blood glucose decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Victoza and Glucophage?

Can you answer these questions?

More questions for: Victoza, Glucophage

You may be interested in these reviews

More reviews for: Victoza, Glucophage

On eHealthMe, Victoza (liraglutide) is often used to treat type 2 diabetes. Glucophage (metformin hydrochloride) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.